Hungary
Subsections:
1. Prevalence of Drug Use in Adult Population in Hungary
"In a survey9 performed in spring 2013 the measured lifetime prevalence of illicit drug10 use of the respondents (N=1959) in the 19-64 year-old age group was 8.2%. The annual prevalence rate was 1.7%. 21.1% of ever users had used an illicit substance in the past year (the proportion of new users was 6%, and that of the current, continuous users was 15.1%). The measured monthly prevalence of illicit drug use was 0.8%, the proportion of current users within ever users was 9.7%.11 Drog Fókuszpont, "2014 National Report (2013 Data) to the EMCDDA by the Reitox National Focal Point - Hungary: New Development, Trends" (Budapest, Hungary: Drog Focuszpont 2014), pp. 16-17. |
2. Age of Initiation of Use in Hungary "In the examined adult population the first illicit drug use took place most frequently at the age of 17 and at the age of 18 and a half on average. More than a half (55%) of ever users tried illicit drugs at the age of 18 or younger, every sixth-seventh user (15.3%) had already used drugs at the age of 15 and every fourth user at the age of 16. Drog Fókuszpont, "2014 National Report (2013 Data) to the EMCDDA by the Reitox National Focal Point - Hungary: New Development, Trends" (Budapest, Hungary: Drog Focuszpont 2014), pp. 19-20. |
3. Prevalence of Drug Use Among Youth in Hungary "The fifth survey11 of the ESPAD series was carried out in 2011 (Elekes 2012). 19.9% of the 16-year-old pupils interviewed have already used illicit drugs in their lives. The differences by gender were not significant, among boys the proportion was 20.9%, while among girls it was 18.9%. The proportion of those who used any substance with the purpose of abuse was higher, 24.9%12. The lifetime prevalence of the use of substances with the purpose of abuse was 26% among boys and 23.7% among girls. (The difference is not significant.) The lifetime prevalence of the misuse of medicines13 was higher among girls: 18.7%, while among boys it was 11.1% (p=0.000). The lifetime prevalence relating to the entire sample was 14.7%. Among the 16-year-old pupils interviewed the lifetime prevalence of all (illicit and licit) substance use was 28.8%. 28.3% of boys and 29.4% of girls have already used a substance suitable for misuse in their lives." Drog Fókuszpont, "HUNGARY: 2012 National Report to the EMCDDA by the Reitox National Focal Point - New Development, Trends and in-depth information on selected issues" (Budapest, Hungary: Drog Focuszpont 2012), p. 15. |
4. Age of First Use Among Youth in Hungary "The age of first use of illicit drugs is different in the different grades. In grade 9 the highest proportion of pupils first tried drugs at the age of 14-15, the mode is 14 years both in the case of cannabis and other drugs, while 60% of the pupils in grade 11 typically tried drugs at the age of 16 or later. At the same time there is no significant difference between the grades if concerning the age of first cannabis and other drugs use." Drog Fókuszpont (Reitox National Focal Point for Hungary), “HUNGARY: 2011 National Report to the EMCDDA - New development, trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2012), p. 14. |
5. Prevalence Among Youth, by Gender and Substance "Generally the lifetime prevalence rates are significantly higher among boys and in older age groups. The exceptions are the use of ecstasy and the misuse of medicines. In the case of the former the age-related patterns do not appear significantly, while in the case of the latter the prevalence of use is the same in both grades among boys and girls. Drog Fókuszpont (Reitox National Focal Point for Hungary), “HUNGARY: 2011 National Report to the EMCDDA - New development, trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2012), p. 15. |
6. Prevalence and Trends in Drug Use in Hungary "Examining the changes between 2007 and 2013, there is no change to the measured lifetime prevalence within the limits of error, while with respect to the shorter-term prevalence rates and the continuous use rate a reduction took place15 at a two-thirds reliability level. The intensive increase indicated in recent years by studies performed in young populations does not appear in the data obtained with respect to the adult population. Drog Fókuszpont, "2014 National Report (2013 Data) to the EMCDDA by the Reitox National Focal Point - Hungary: New Development, Trends" (Budapest, Hungary: Drog Focuszpont 2014), pp. 20-21. |
7. Prevalence of Use by Drug Type in Hungary "Based on both lifetime and last year prevalence rates by substance cannabis was the most widespread (LTP [Lifetime Prevalence] was 9.8%, LYP [Last Year Prevalence] was 3.9%). Incidence of all the other substances was much lower in the adult population. Based on lifetime prevalence ecstasy and amphetamines ranked second and third, their spread showed no considerable difference. LSD was hardly behind them at the fourth place. Lifetime prevalence of all other illicit drugs was lower than 1%." Drog Fókuszpont (Reitox National Focal Point for Hungary), “HUNGARY: 2004 National Report to the EMCDDA - New Development, Trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2004), p. 18. |
8. Drug Offenses in Hungary 2011 "In 2013 a total of 5,545 procedures launched due to offences concerning the misuse of illicit drugs were concluded. (ST11_2014_HU_01) As compared to the previous year, the number of registered drug offences rose by 6.3%. Drog Fókuszpont, "2014 National Report (2013 Data) to the EMCDDA by the Reitox National Focal Point - Hungary: New Development, Trends" (Budapest, Hungary: Drog Focuszpont 2014), pp. 81-82. |
9. Drug Offenses by Drug Type in Hungary 2013 "68.4% (3,775 cases) of the 5,545 registered drug offences involved cannabis. 17.3% of the offences were committed with amphetamine, 2.5% with cocaine, 1.8% with MDMA (ecstasy), 1.2% with heroin, and 0.9% with methamphetamine. (ST11_2014_HU_01) 190 cases (3.4%) were registered with the subject of the abuse being a new psychoactive substance. Of the investigations launched in connection with new psychoactive substances, 31% were initiated due to misuse of synthetic cannabinoids, 41% due to misuse of cathinone derivatives, 7% due to phenethylamine derivatives, 9% due to GBL and the remaining 12% due to misuse of other new psychoactive substances. The subject of perpetration was a substance listed in the “Other” category in 232 cases (4.2%), among these, morphine was the subject of perpetration in 37 cases, methadone in 22 cases, ketamine in 24 cases, GHB in 10 cases. In 4 cases the crime was committed with a precursor, and in 23 cases the subject of perpetration was not recorded. Drog Fókuszpont, "2014 National Report (2013 Data) to the EMCDDA by the Reitox National Focal Point - Hungary: New Development, Trends" (Budapest, Hungary: Drog Focuszpont 2014), p. 82.0 |
10. Drug Offenses by Offense Type in Hungary 2011 "In 2013 among all registered drug offences the proportion of demand-related perpetrations was 87.8% (4,868 cases), and the proportion of supply-related perpetrations was 12.2% (677 cases). In the two previous years demand/supply related perpetrations occurred in these same proportions among the drug-related offences. (ST11_2014_HU_01) Drog Fókuszpont, "2014 National Report (2013 Data) to the EMCDDA by the Reitox National Focal Point - Hungary: New Development, Trends" (Budapest, Hungary: Drog Focuszpont 2014), p. 83. |
11. Drug Offenses by Amount of Drugs Involved, Hungary 2011 "In 2011 small amounts of drugs were involved in 88.2% of the registered drug offences (demand-related perpetrations: 91.5%, supply-related perpetrations: 64.8%). As compared to the previous year the proportion of offences small amounts of drugs continued to increase due to the slight increase of demand-related perpetrations involving small amounts. Drog Focuszpont, "HUNGARY: 2012 National Report to the EMCDDA by the Reitox National Focal Point - New Development, Trends and in-depth information on selected issues" (Budapest, Hungary: Drog Focuszpont 2012), p. 82. |
12. Prevalence and Characteristics of Injection Drug Use in Hungary 2010 "In 2010 17 organisations reported drug use pattern and demographic data on 2,708 clients (Tarján 2011). In respect of age distribution it can be stated that in 2010 again the greatest proportion, 48% of the clients of NSPs was formed by clients aged 25 to 34. Clients below the age of 25 and above the age of 34 were represented in nearly the same proportion, 26% each. Drog Focuszpont (Reitox National Focal Point for Hungary), “HUNGARY: 2011 National Report to the EMCDDA - New development, trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2012), p. 29. |
13. Substitution Treatment Availability and Usage in Hungary 2011 "In 2011, in the course of the pilot data collection coordinated by the National Centre for Addictions, 9 service providers reported clients participating in methadone or buprenorphine-naloxone treatment (out of the 12 service providers providing such treatments in the country). On the basis of the service providers? reports a total number of 715 clients received methadone or buprenorphine-naloxone treatment during the year. This value indicates a 31% drop as compared to the 1031 cases reported in the previous year, and this is due to the coverage of data collection and to the measures to control double counting58. In summary the quality of the data improved, but coverage slightly decreased (from about 98% to 90% of the cases). Drog Focuszpont, "HUNGARY: 2012 National Report to the EMCDDA by the Reitox National Focal Point - New Development, Trends and in-depth information on selected issues" (Budapest, Hungary: Drog Focuszpont 2012), pp. 43-44. |
14. Characteristics of Clients Entering Treatment in Hungary 2011 "In 2011 new clients treated for drug use were reported by 85 treatment units. 36 further institutes reported that although they were entitled to treat drug users, they had no such clients during the year. 53 out of the 85 units treated clients in the scope of outpatient service, 16 units in the scope of inpatient service, 22 units in the scope of low-threshold service, and 6 units reported the treatment of prisoners63. Drog Focuszpont, "HUNGARY: 2012 National Report to the EMCDDA by the Reitox National Focal Point - New Development, Trends and in-depth information on selected issues" (Budapest, Hungary: Drog Focuszpont 2012), pp. 44-45. |
15. Persons Entering Treatment for Cannabis Use in Hungary 2011 "In 2011 the number and proportion of clients entering treatment because of cannabis use did not change substantially as compared to the year before. A total number of 3,321 persons started treatment or joined some sort of indicated prevention programme (preventive-consulting service), 543 persons (16%) voluntarily and 2,985 persons (91%) as an alternative to criminal procedure. Among cannabis users 2,492 persons (81%) entered treatment for the first time in their lives. Drog Focuszpont, "HUNGARY: 2012 National Report to the EMCDDA by the Reitox National Focal Point - New Development, Trends and in-depth information on selected issues" (Budapest, Hungary: Drog Focuszpont 2012), pp. 47-48. |
16. Quasi Compulsory Treatment [QCT] as Alternative to Incarceration in Hungary 2011 "In 2011 3,453 persons entered treatment as an alternative to criminal procedure. Similarly to the year before, no significant change can be observed in the substance distribution structure of clients starting QCT programmes as compared to the previous year: the proportion of cannabis users (80%), stimulant users (13%) and opiate users (3%) remained practically the same. Consequently, the changes observed among clients not participating in QCT still cannot be observed among clients participating in QCT programmes." Drog Focuszpont, "HUNGARY: 2012 National Report to the EMCDDA by the Reitox National Focal Point - New Development, Trends and in-depth information on selected issues" (Budapest, Hungary: Drog Focuszpont 2012), p. 46. |
17. Needle and Syringe Programs (NSPs) in Hungary 2011 "In 2011 24 organisations100 were running NSP services in Hungary (Tarján 2012b) (ST10_2012_HU_01;16 HU_ST10_2012). Drog Focuszpont, "HUNGARY: 2012 National Report to the EMCDDA by the Reitox National Focal Point - New Development, Trends and in-depth information on selected issues" (Budapest, Hungary: Drog Focuszpont 2012), pp. 69-70. |
18. Other Services Provided by Needle and Syringe Programs in Hungary 2011 "In 2011 a telephone survey74 was carried out among 21 NSPs, including fixed, mobile and street outreach programmes, to examine what other sterile equipments and services are provided to clients apart from syringes. Besides sterile syringes, the majority of the organisations distribute alcohol pads, condoms, filters, sterile mixing containers and ascorbic acid. The organisations also often distribute vitamins and vein protection cream to clients. (SQ23_2011_HU_01) Drog Focuszpont (Reitox National Focal Point for Hungary), “HUNGARY: 2011 National Report to the EMCDDA - New development, trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2012), p. 64. |
19. Implementation of the National Drug Control Plan in Hungary
"No action plan was drawn up for 2011, the execution of the tasks associated with handling the drug problem was performed by the National Drug Prevention Coordination Department of the Youth Affairs Division under the professional control of the State Secretariat for Social, Family and Youth Affairs of the Ministry of National Resources (NEFMI).6 Drog Focuszpont, "HUNGARY: 2012 National Report to the EMCDDA by the Reitox National Focal Point - New Development, Trends and in-depth information on selected issues" (Budapest, Hungary: Drog Focuszpont 2012), p. 11. |
20. Progress in Developing Hungarian National Drug Strategy "In December 2010 the government decided to prepare a new basic drug policy document. In 2011 the ministry asked the head of the National Drug Prevention Office and 11 experts to prepare the new drug strategy. The strategy draft elaborated by the group of experts is centred around a drug free life model and the communication of health as a basic value, while with regards to the treatment of drug users it promotes a recovery-based approach. On the basis of legal obligations the draft is to be completed with strategic public administration elements in the first six months of 2012 and will be submitted to the Government in the second part of 2012." Drog Focuszpont, "HUNGARY: 2012 National Report to the EMCDDA by the Reitox National Focal Point - New Development, Trends and in-depth information on selected issues" (Budapest, Hungary: Drog Focuszpont 2012), p. 11. |
21. Structure for Drug Control Coordination "On the basis of directive 6/2010. (X. 19.) NEFMI of the Ministry of National Resources on the Organisational and Operational Rules of the Ministry of National Resources, following the structural reorganisation of central government drug coordination tasks are now performed by the National Drug Prevention Coordination Department of the Youth Affairs Division under the professional control of the State Secretariat for Social, Family and Youth Affairs of the Ministry of National Resources (NEFMI). The national drug coordinator is the head of the Drug Prevention Coordination Department. The former drug coordinator was recalled in December 2010, and the new drug coordinator was appointed on 1 February 2011. Drog Focuszpont (Reitox National Focal Point for Hungary), “HUNGARY: 2011 National Report to the EMCDDA - New development, trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2012), pp. 11-12. |
22. Drug Control Spending, Hungary "In 2010 an amount of EUR 3,484,5734 was available for the performance of tasks relating to drug use in the budget of the Ministry of National Resources (NEFMI) (earlier in the budget of the Ministry of Social Affairs and Labour), but after fulfilling the budget allocation obligation announced in June 2010 the annual budget dropped to EUR 2,620,689 (NEFMI 2011). A significant proportion of the budget amount was used in the framework of the tender system for performing the development tasks defined in the National Strategy. The amount of support granted was EUR 1,796,733. There was a total number of 434 winning projects. Drog Focuszpont (Reitox National Focal Point for Hungary), “HUNGARY: 2011 National Report to the EMCDDA - New development, trends and in-depth information on selected issues" (Lisbon, Portugal: EMCDDA, 2012), pp. 12-13. |